Literature DB >> 24025765

Differential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42.

Min-gen Fu1, Shuo Li, Ting-ting Yu, Li-juan Qian, Ri-sheng Cao, Hong Zhu, Bin Xiao, Chun-hua Jiao, Na-na Tang, Jing-jing Ma, Jie Hua, Wei-feng Zhang, Hong-jie Zhang, Rui-hua Shi.   

Abstract

MicroRNAs (miRNA) have played an important role in carcinogenesis. In this study, Agilent miRNA microarray was used to identify differentially expressed miRNAs in esophageal squamous cell carcinoma (ESCC) tissues and miR-195 was downregulated in ESCC compared with normal esophageal tissues. Moreover, Cdc42 was confirmed as target gene of miR-195. Ectopic expression of miR-195 in ESCC cells significantly downregulated Cdc42 by directly binding its 3' untranslated regions, and induced G1 cell cycle arrest, leading to a significant decrease in cell growth, migration, and invasion in vitro. Therefore, our findings demonstrated that miR-195 may act as a tumor suppressor in ESCC by targeting Cdc42.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cdc42; Esophageal squamous cell carcinoma; Tumor progression; miR-195; miRNA

Mesh:

Substances:

Year:  2013        PMID: 24025765     DOI: 10.1016/j.febslet.2013.08.036

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

Review 1.  The role of microRNA in esophageal squamous cell carcinoma.

Authors:  Kazuto Harada; Yoshifumi Baba; Takatsugu Ishimoto; Hironobu Shigaki; Keisuke Kosumi; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

2.  microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.

Authors:  Niuniu Sun; Lin Ye; Tingmin Chang; Xiaojing Li; Xiumin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer.

Authors:  Yongqiang Li; Zhi Wang; Yijiang Li; Ruijun Jing
Journal:  Oncol Lett       Date:  2017-03-22       Impact factor: 2.967

Review 4.  MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy.

Authors:  Peter Igaz; Ivan Igaz; Zoltán Nagy; Gábor Nyírő; Peter M Szabó; András Falus; Attila Patócs; Károly Rácz
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

5.  miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.

Authors:  Chao Cai; Qing-Biao Chen; Zhao-Dong Han; Yan-Qiong Zhang; Hui-Chan He; Jia-Hong Chen; Yan-Ru Chen; Sheng-Bang Yang; Yong-Ding Wu; Yan-Ru Zeng; Guo-Qiang Qin; Yu-Xiang Liang; Qi-Shan Dai; Fu-Neng Jiang; Shu-lin Wu; Guo-Hua Zeng; Wei-De Zhong; Chin-Lee Wu
Journal:  Clin Cancer Res       Date:  2015-06-16       Impact factor: 12.531

6.  miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis.

Authors:  Maria Ines Almeida; Andreia Machado Silva; Daniel Marques Vasconcelos; Catarina Rodrigues Almeida; Hugo Caires; Marta Teixeira Pinto; George Adrian Calin; Susana Gomes Santos; Mário Adolfo Barbosa
Journal:  Oncotarget       Date:  2016-01-05

7.  MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancer.

Authors:  Geeta Rao; Shailendra Kumar Dhar Dwivedi; Yushan Zhang; Anindya Dey; Khader Shameer; Ramachandran Karthik; Subramanya Srikantan; Md Nazir Hossen; Jonathan D Wren; Muniswamy Madesh; Joel T Dudley; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  EMBO Rep       Date:  2020-08-27       Impact factor: 9.071

8.  Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.

Authors:  Xiaoyan He; Zhimei Zhang; Ming Li; Shuo Li; Lihua Ren; Hong Zhu; Bin Xiao; Ruihua Shi
Journal:  BMC Cancer       Date:  2015-08-06       Impact factor: 4.430

9.  Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients.

Authors:  Isolde Summerer; Maximilian Niyazi; Kristian Unger; Adriana Pitea; Verena Zangen; Julia Hess; Michael J Atkinson; Claus Belka; Simone Moertl; Horst Zitzelsberger
Journal:  Radiat Oncol       Date:  2013-12-28       Impact factor: 3.481

10.  MiR-195 affects cell migration and cell proliferation by down-regulating DIEXF in Hirschsprung's disease.

Authors:  Hao Lei; Junwei Tang; Hongxing Li; Hongwei Zhang; Changgui Lu; Huan Chen; Wei Li; Yankai Xia; Weibing Tang
Journal:  BMC Gastroenterol       Date:  2014-07-09       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.